- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advance Malignancies in Germany
Total 381 results
-
AstraZenecaCompletedAdvanced Solid MalignanciesRussian Federation, Germany
-
German Cancer Research CenterGerman Consortium for Translational Cancer ResearchCompletedMetastatic and Locally Advanced NRG1-rearranged MalignanciesGermany
-
German Cancer Research CenterRecruiting
-
4SC AGCompletedAdvanced Hematologic MalignanciesGermany
-
AstraZenecaTerminatedCancer | Advanced Solid MalignanciesUnited States, Italy, United Kingdom, France, Germany, Spain, Netherlands
-
Charite University, Berlin, GermanyUniversity of LeipzigUnknownAcute Myeloid Leukemias | Advanced Hematological Malignancies | Indication for Allogeneic Stem Cell Transplantation | no HLA-identical Donor AvailableGermany
-
iOMEDICO AGBristol-Myers Squibb; Roche Pharma AGCompletedAdvanced Solid Tumors or Hematologic MalignanciesGermany
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited States, Germany, Italy, United Kingdom, Canada, France, Korea, Republic of, Netherlands
-
AstraZenecaParexelCompletedSolid and Hematological MalignanciesGermany
-
Novartis PharmaceuticalsActive, not recruitingAdvanced Malignancies That Harbor IDHR132 MutationsBelgium, Germany, Spain, Canada, Australia, United States, Netherlands, Singapore
-
Technical University of MunichRecruiting
-
University Hospital TuebingenRecruitingHematologic MalignancyGermany
-
AstraZenecaRecruitingAdvanced Solid MalignanciesUnited States, Korea, Republic of, Spain, Australia, Sweden, Germany, United Kingdom
-
University Hospital TuebingenCompletedHematologic MalignanciesGermany
-
Heinrich-Heine University, DuesseldorfLudwig-Maximilians - University of Munich; Federal Ministry of Health, Germany and other collaboratorsCompletedNursing Homes | Advance Care PlanningGermany
-
University Hospital HeidelbergHeidelberg University; University of Jena; Martin-Luther-Universität Halle-Wittenberg and other collaboratorsRecruiting
-
Silence Therapeutics GmbHCompleted
-
University Hospital TuebingenRecruitingAdvanced CancerGermany
-
Ludwig-Maximilians - University of MunichCankado GmbHCompleted
-
medac GmbHCompletedHematological MalignanciesGermany, Finland, Poland, Sweden
-
Charite University, Berlin, GermanyUnknownHematological Malignancies | Hematological DiseasesGermany
-
Novartis PharmaceuticalsCompletedHematological MalignanciesGermany, Switzerland, France
-
BeiGeneRecruitingMature B-Cell MalignanciesUnited States, Italy, Australia, New Zealand, Spain, United Kingdom, Germany
-
Heidelberg UniversityCompletedSinonasal Malignancies | Adenocarcinoma and Squamous Cell Carcinoma of the Paranasal SinusesGermany
-
Kite, A Gilead CompanyEnrolling by invitationSolid and Hematological MalignanciesUnited States, Netherlands, Japan, Australia, France, Israel, Germany, Canada, United Kingdom
-
Krankenhaus NordwestTerminatedHer2/Neu Positive Advanced Solid TumorsGermany
-
Novartis PharmaceuticalsRecruitingALK Positive MalignanciesGermany, France, Australia, Belgium, Italy, Korea, Republic of, Poland, China, United States, Taiwan, Brazil, Bulgaria, Hong Kong, Japan, Lebanon, Malaysia, Spain, Russian Federation, Colombia, Singapore, Czechia
-
Hannover Medical SchoolCompleted
-
BioPheresis GmbHDr. M. Koehler GmbH; ARTIMED Medical Consulting GmbHTerminatedAdvanced Cancer EntitiesGermany
-
University Hospital of CologneRadboud University Medical CenterCompletedInvasive AspergillosisGermany, Netherlands
-
EMD SeronoTerminatedHaematological MalignanciesItaly, United States, Switzerland, Belgium, Germany
-
Beckman Coulter, Inc.Completed
-
University Hospital TuebingenActive, not recruitingSolid Tumor | Influenza | SARS-CoV-2 | Hematologic MalignancyGermany
-
University Hospital of CologneRecruitingCancer | Neutropenia | Chemotherapy | Hematological Malignancies | ImmunosuppressionGermany
-
Blueprint Medicines CorporationRecruitingAdvanced Systemic MastocytosisUnited States, Norway, Netherlands, Belgium, Germany, France, Spain
-
Krankenhaus NordwestCompletedAdvanced Gastric Cancer | Advanced Cancer of the Esophagogastric JunctionGermany
-
AstraZenecaTerminatedStudy of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological MalignanciesHaematological MalignanciesFrance, Italy, United States, Korea, Republic of, Germany, Australia
-
Gerhild BeckerRecruitingPain | Nausea | Vomiting | Advanced CancerGermany
-
PD. Dr. med. Carola SeifartGerman Federal Ministry of Education and Research; Philipps University Marburg... and other collaboratorsUnknownNeoplasms | Advanced Cancer | End Stage CancerGermany
-
AGC Biologics S.p.A.CompletedHematological MalignanciesItaly, Israel, United Kingdom, Germany, Greece
-
University of Erlangen-Nürnberg Medical SchoolUnknownLymphoma | Hematologic Diseases | Leukemia | Cancer | Myeloma | Cachexia; CancerGermany
-
Munich Leukemia LaboratoryRecruitingLymphoma | Leukemia | Hematologic Malignancy | Minimal Residual Disease | Blood CancerGermany
-
Clavis PharmaCompletedAML | Hematologic MalignanciesUnited States, United Kingdom, France, Germany, Italy, Norway
-
German Cancer Research CenterUniversity Hospital Heidelberg; National Center for Tumor Diseases, HeidelbergCompleted
-
Munich Leukemia LaboratoryIllumina, Inc.RecruitingLeukemia | Rare Diseases | Refractory Lymphoma | Hematologic Malignancy | Refractory Leukemia | Unknown Primary TumorsGermany
-
University Hospital FreiburgCompletedAdvanced CancerGermany
-
AstraZenecaRecruitingHematological MalignanciesUnited States, Spain, Korea, Republic of, Italy, China, Japan, Taiwan, Australia, Germany
-
Philogen S.p.A.Syneos HealthCompleted
-
Goethe UniversityAgaplesion Markus Krankenhaus gGmbHCompletedAdvanced Gastrointestinal CancerGermany
-
Apceth GmbH & Co. KGTerminatedAdvanced Gastrointestinal CancerGermany